Curaleaf International, a market-leading global cannabis company, has been announced as the Headline Partner for the prestigious Cannabis Europa conference. The conference, Europe’s foremost event for cannabis, is scheduled to take place in London on June 25-26, 2024.
Cannabis Europa brings together influential leaders in science, policy, and business to drive progress and responsible growth in the European cannabis industry. With a focus on innovation, regulation, and investment opportunities, the conference serves as a platform for collaboration and education for business leaders, policymakers, investors, patients, and advocates.
As the Headline Partner for Cannabis Europa, Curaleaf International brings its unparalleled expertise and commitment to advancing the medical cannabis industry in Europe. With a strong emphasis on research and scientific rigor, Curaleaf International sets the standard for the industry and is on a rapid growth trajectory.
According to forecasts published by Prohibition Partners in The European Cannabis Report: 8th Edition, Europe’s medical cannabis market is expected to be worth nearly €2.2 billion by 2027, serving 1.5 million patients in the region.
“We are excited to partner with Cannabis Europa for this groundbreaking event,” said Juan Martinez, Head of Curaleaf International. “As a leading global cannabis company, we are deeply committed to driving positive change and shaping the future of the industry. Cannabis Europa provides an invaluable platform for collaboration, innovation, and education, and we look forward to contributing to meaningful discussions and insights at the conference.”
Cannabis Europa and Prohibition Partners co-founder and CEO, Stephen Murphy, added, “Since 2018, Cannabis Europa has been a destination for industry and policy leaders to converge and shape the future of cannabis. We are delighted to have Curaleaf International as the Headline Partner for this year’s conference in London. As a global leader in the cannabis industry, Curaleaf International is supporting positive change in healthcare and setting the standards for a fledgling industry.”
The London conference will feature a diverse lineup of speakers, including industry experts, politicians, healthcare professionals, and investors, who will explore topics such as medical advancements, regulatory frameworks, investment opportunities, and global market trends.
For more information about Cannabis Europa and to register for the conference, please visit: www.cannabis-europa.com.
For media inquiries or interview requests, please contact Mike Hoban, Head of Marketing & Communications at Prohibition Partners, at +44(0)7841 697 433 or michael@prohibitionpartners.com.
About Cannabis Europa:
Cannabis Europa conferences connect influential leaders in science, policy, and business to build a responsible and effective European cannabis industry that promotes innovation, access, and growth. Their events are a catalyst for political change and provide a platform for cannabis-related businesses to connect with mainstream brands.
The inaugural Cannabis Europa conference took place in 2018 at the Barbican in London. Within a month, the UK’s Home Office acknowledged the medical benefits of cannabis and began reviewing their stance on its use as medicine, paving the way for patient access. Since then, Cannabis Europa has continued to shape the future of cannabis, hosting industry-leading conferences in Paris (2019), London (2019), Toronto (2019), New York (2019), Madrid (2020), and London (2021, 2022, 2023).
About Curaleaf International:
Curaleaf International is one of the largest vertically integrated cannabis companies in Europe, with a unique supply and distribution network throughout the region. They bring together cutting-edge cultivation, extraction, and production with pioneering science and research to deliver safe, reliable, and effective care to patients.
Curaleaf International’s subsidiary network includes Curaleaf Clinic, Curaleaf Pharmacy, and Curaleaf Laboratories in the UK, as well as the Terra Verde cultivation facility in Portugal, the Medalchemy research and development site in Spain, the Four20 Pharma wholesaler and distributor in Germany, and the Polish wholesaler Can4Med.
Curaleaf International is part of Curaleaf Holdings, Inc., a leading global cannabis company listed on the Toronto Stock Exchange (TSX) and trading on the OTCQX market under the symbol CURLF.
Press release distributed by Pressat on behalf of Curaleaf International, on Thursday 21 March, 2024. For more information subscribe and follow https://pressat.co.uk/
Thursday 21 March, 2024
London, UK – March 21, 2024 – Curaleaf International has been announced as the Headline Partner for Cannabis Europa, Europe’s most prestigious conference for the cannabis industry. The conference is set to take place in London on June 25-26, 2024.
Cannabis Europa brings together influential leaders in science, policy, and business to drive responsible growth and progress in the European cannabis industry. With a focus on innovation, regulation, and investment opportunities, the conference serves as a platform
